Summary
This systematic review and meta-analysis, published in Environmental Research in 2023, quantitatively synthesises evidence on the relationship between organophosphate pesticide exposure and metabolic syndrome risk. By pooling data from multiple observational studies, it likely demonstrates a statistically significant positive association between OP exposure — typically assessed via urinary biomarkers — and metabolic syndrome or its constituent components. The review contributes to the growing body of evidence implicating environmental pesticide exposure as a potential driver of cardiometabolic disease burden.
UK applicability
Although the study is international in scope, findings are highly relevant to UK public health and regulatory policy, particularly in the context of post-Brexit pesticide authorisation reviews and dietary exposure assessments conducted by the UK Health Security Agency and the Committee on Toxicity.
Key measures
Odds ratio (OR) or relative risk (RR) for metabolic syndrome; prevalence of metabolic syndrome components; urinary organophosphate metabolite concentrations (e.g. dialkyl phosphates)
Outcomes reported
The study synthesised evidence on the association between organophosphate (OP) pesticide exposure and the prevalence or incidence of metabolic syndrome and its components (e.g. obesity, dyslipidaemia, insulin resistance, hypertension). It likely reports pooled odds ratios or relative risks from included observational studies.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.